SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-063019
Filing Date
2023-11-13
Accepted
2023-11-13 16:30:16
Documents
15
Period of Report
2023-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K revb-20231113.htm   iXBRL 8-K 51628
2 EX-99.1 revb-ex99_1.htm EX-99.1 220163
3 GRAPHIC img220778470_0.jpg GRAPHIC 18521
  Complete submission text file 0000950170-23-063019.txt   470322

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT revb-20231113.xsd EX-101.SCH 3514
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT revb-20231113_pre.xml EX-101.PRE 13721
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT revb-20231113_lab.xml EX-101.LAB 19062
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT revb-20231113_def.xml EX-101.DEF 14413
9 EXTRACTED XBRL INSTANCE DOCUMENT revb-20231113_htm.xml XML 6958
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39603 | Film No.: 231399294
SIC: 2834 Pharmaceutical Preparations